Michigan man suing COVID drug manufacturer after suffering two massive strokes

By ANDRES GUTIERREZ

Click here for updates on this story

    SOUTHFIELD, Michigan (WWJ) — A Lenawee County man is suing a COVID drug manufacturer and a Washtenaw County hospital after suffering two massive strokes.

Dan Nowacki’s wife Kathleen and their son Luke are now providing round-the-clock care because of what they say was a tainted COVID drug.

Their attorneys at Ven Johnson Law are suing the maker of Remdesivir over claims that the drug had glass particles when staff at St. Joseph Mercy Hospital in Chelsea gave it to him in November 2021.

“One of the things that we’re going to define in this lawsuit, and we’re going to figure out is exactly what did they know when,” Ven Johnson said during a news conference on Tuesday.

The lawsuit claims that of the five doses Nowacki received during his stay, at least two were from the bad batch.

A few days later, he suffered a stroke.

The drug maker, Gilead Sciences, Inc., issued a voluntary recall the following month.

“Once Gilead came forward in the first week of December, why weren’t the patients located? And it was discovered, so maybe Dan could have been spared his second stroke in December,” Johnson said.

But Nowacki and his family weren’t made aware of it until several months later, in April 2022, when the hospital sent a letter confirming he was given at least two doses that were part of the nationwide recall.

“Their argument, ladies and gentlemen, has been, ‘Yeah, we know we voluntarily recalled. Yeah, we know there’s glass particulate in it, and we know that two doses were given to Dan, and we know we had a stroke. But since we followed the FDA guidelines and were approved, we have drug immunity. You can’t sue us because it was approved by the FDA.'”

But a Michigan judge ruled for the first time that the “Public Readiness and Emergency Preparedness” (PREP) Act does not shield a drugmaker from liability when its medication is contaminated with glass particles.

“FDA never approved this drug in the form that it was given to Mr. Nowacki, period,” Ken Khara, attorney at Ven Johnson Law, said.

A spokesperson for the hospital said they are aware of the ruling and cannot comment during ongoing litigation.

Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.